168 related articles for article (PubMed ID: 20527959)
21. [Metabonomic variation of esophageal cancer within different ethnic groups in Xinjiang, China].
Ayxiam H; Ma H; Ilyar S; Zhang LW; Ablizi A; Batur M; Lu XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):591-6. PubMed ID: 19954070
[TBL] [Abstract][Full Text] [Related]
22. [Significance of plasma interleukin-6 in the diagnosis of renal cell carcinoma].
Kamemoto H
Hinyokika Kiyo; 1993 Apr; 39(4):301-6. PubMed ID: 8503325
[TBL] [Abstract][Full Text] [Related]
23. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
24. Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients.
Le Moyec L; Valensi P; Charniot JC; Hantz E; Albertini JP
NMR Biomed; 2005 Nov; 18(7):421-9. PubMed ID: 16075416
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival.
Vasudev NS; Brown JE; Brown SR; Rafiq R; Morgan R; Patel PM; O'Donnell D; Harnden P; Rogers M; Cocks K; Anderson K; Paul A; Eardley I; Selby PJ; Banks RE
Clin Cancer Res; 2008 Mar; 14(6):1775-81. PubMed ID: 18347179
[TBL] [Abstract][Full Text] [Related]
26. An NMR-based metabonomic investigation of the subacute effects of melamine in rats.
Sun YJ; Wang HP; Liang YJ; Yang L; Li W; Wu YJ
J Proteome Res; 2012 Apr; 11(4):2544-50. PubMed ID: 22401608
[TBL] [Abstract][Full Text] [Related]
27. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration.
Bu Q; Yan G; Deng P; Peng F; Lin H; Xu Y; Cao Z; Zhou T; Xue A; Wang Y; Cen X; Zhao YL
Nanotechnology; 2010 Mar; 21(12):125105. PubMed ID: 20203358
[TBL] [Abstract][Full Text] [Related]
28. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
29. Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D (1) H INADEQUATE NMR.
Martineau E; Tea I; Akoka S; Giraudeau P
NMR Biomed; 2012 Aug; 25(8):985-92. PubMed ID: 22331830
[TBL] [Abstract][Full Text] [Related]
30. Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis.
Sonkar K; Purusottam RN; Sinha N
Anal Chem; 2012 May; 84(9):4063-70. PubMed ID: 22472063
[TBL] [Abstract][Full Text] [Related]
31. Metabolomic analysis of the plasma of patients with high-altitude pulmonary edema (HAPE) using 1H NMR.
Luo Y; Zhu J; Gao Y
Mol Biosyst; 2012 Jun; 8(6):1783-8. PubMed ID: 22498880
[TBL] [Abstract][Full Text] [Related]
32. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
33. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Loening SA; Jung K
Cancer Lett; 2008 Sep; 269(1):85-92. PubMed ID: 18504068
[TBL] [Abstract][Full Text] [Related]
34. The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy.
Daykin CA; Foxall PJ; Connor SC; Lindon JC; Nicholson JK
Anal Biochem; 2002 May; 304(2):220-30. PubMed ID: 12009699
[TBL] [Abstract][Full Text] [Related]
35. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases.
Gao H; Dong B; Jia J; Zhu H; Diao C; Yan Z; Huang Y; Li X
J Cancer Res Clin Oncol; 2012 May; 138(5):753-61. PubMed ID: 22258851
[TBL] [Abstract][Full Text] [Related]
36. (1)H NMR based metabonomics of human amniotic fluid for the metabolic characterization of fetus malformations.
Graça G; Duarte IF; Barros AS; Goodfellow BJ; Diaz S; Carreira IM; Couceiro AB; Galhano E; Gil AM
J Proteome Res; 2009 Aug; 8(8):4144-50. PubMed ID: 19453159
[TBL] [Abstract][Full Text] [Related]
37. NMR metabolic analysis of samples using fuzzy K-means clustering.
Cuperlović-Culf M; Belacel N; Culf AS; Chute IC; Ouellette RJ; Burton IW; Karakach TK; Walter JA
Magn Reson Chem; 2009 Dec; 47 Suppl 1():S96-104. PubMed ID: 19731396
[TBL] [Abstract][Full Text] [Related]
38. Panel of candidate biomarkers for renal cell carcinoma.
Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
[TBL] [Abstract][Full Text] [Related]
40. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy.
Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Humpfer E; Spraul M; Carreira IM; Melo JB; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2010 Jan; 9(1):319-32. PubMed ID: 19908917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
